loadpatents
name:-0.005281925201416
name:-0.007072925567627
name:-0.0026850700378418
HERZIG; Stephan Patent Filings

HERZIG; Stephan

Patent Applications and Registrations

Patent applications and USPTO patent grants for HERZIG; Stephan.The latest application filed is for "microrna inhibitors for use in treating metabolic diseases".

Company Profile
2.6.4
  • HERZIG; Stephan - Vaterstetten DE
  • Herzig; Stephan - Baldham DE
  • - BALDHAM DE
  • Herzig; Stephan - Gaiberg DE
  • Herzig; Stephan - Del Mar CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Microrna Inhibitors For Use In Treating Metabolic Diseases
App 20210254067 - HERZIG; Stephan ;   et al.
2021-08-19
Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistance
Grant 11,053,499 - Herzig , et al. July 6, 2
2021-07-06
Oligonucleotide Sequences Targeting Transcription Factor Tsc22d4 For The Treatment Of Insulin Resistance
App 20200255834A1 -
2020-08-13
Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistance
Grant 10,676,739 - Herzig , et al.
2020-06-09
MicroRNAs modulating the effect of glucocorticoid signaling
Grant 10,041,070 - Berriel Diaz , et al. August 7, 2
2018-08-07
Treatment of insulin resistance through inhibitors of transcription factor TSC22D4
Grant 9,879,258 - Berriel Diaz , et al. January 30, 2
2018-01-30
Oligonucleotide Sequences Targeting Transcription FactorTSC22D4 for the Treatment of Insulin Resistance
App 20180023078 - HERZIG; Stephan ;   et al.
2018-01-25
MicroRNAs Modulating the Effect of Glucocorticoid Signaling
App 20160251656 - Berriel Diaz; Mauricio ;   et al.
2016-09-01
Treatment of Insulin Resistance Through Inhibitors of Transcription Factor TSC22D4
App 20160115475 - BERRIEL DIAZ; Mauricio ;   et al.
2016-04-28
Protein kinase B/Akt modulators and methods for the use thereof
Grant 7,220,539 - Du , et al. May 22, 2
2007-05-22
Methods for indentifying compounds that modulate gluconeogenesis through the binding of CREB to the PGC-1 promoter
Grant 6,974,671 - Montminy , et al. December 13, 2
2005-12-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed